235 related articles for article (PubMed ID: 24751730)
1. Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.
Aspord C; Tramcourt L; Leloup C; Molens JP; Leccia MT; Charles J; Plumas J
J Invest Dermatol; 2014 Oct; 134(10):2551-2561. PubMed ID: 24751730
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
Yokogawa M; Takaishi M; Nakajima K; Kamijima R; Digiovanni J; Sano S
Mol Carcinog; 2013 Oct; 52(10):760-9. PubMed ID: 22431065
[TBL] [Abstract][Full Text] [Related]
3. Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells.
Huang SW; Kao JK; Wu CY; Wang ST; Lee HC; Liang SM; Chen YJ; Shieh JJ
Oncotarget; 2014 Mar; 5(5):1363-81. PubMed ID: 24658058
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells.
Drobits B; Holcmann M; Amberg N; Swiecki M; Grundtner R; Hammer M; Colonna M; Sibilia M
J Clin Invest; 2012 Feb; 122(2):575-85. PubMed ID: 22251703
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.
Wang ST; Huang SW; Kao JK; Liang SM; Chen YJ; Chen YY; Wu CY; Shieh JJ
J Dermatol Sci; 2015 May; 78(2):108-16. PubMed ID: 25766763
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
[TBL] [Abstract][Full Text] [Related]
8. The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma.
Cho JH; Lee HJ; Ko HJ; Yoon BI; Choe J; Kim KC; Hahn TW; Han JA; Choi SS; Jung YM; Lee KH; Lee YS; Jung YJ
Oncotarget; 2017 Apr; 8(15):24932-24948. PubMed ID: 28212561
[TBL] [Abstract][Full Text] [Related]
9. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of melanoma skin metastases with imiquimod: a review.
Sisti A; Sisti G; Oranges CM
Dermatol Online J; 2015 Feb; 21(2):. PubMed ID: 25756475
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases.
Hesling C; D'Incan M; Mansard S; Franck F; Corbin-Duval A; Chèvenet C; Déchelotte P; Madelmont JC; Veyre A; Souteyrand P; Bignon YJ
Br J Dermatol; 2004 Apr; 150(4):761-7. PubMed ID: 15099376
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
[TBL] [Abstract][Full Text] [Related]
13. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod.
Schön MP; Wienrich BG; Drewniok C; Bong AB; Eberle J; Geilen CC; Gollnick H; Schön M
J Invest Dermatol; 2004 May; 122(5):1266-76. PubMed ID: 15140231
[TBL] [Abstract][Full Text] [Related]
14. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
Kiss J
Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
[TBL] [Abstract][Full Text] [Related]
15. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
16. Human proangiogenic circulating hematopoietic stem and progenitor cells promote tumor growth in an orthotopic melanoma xenograft model.
Mund JA; Shannon H; Sinn AL; Cai S; Wang H; Pradhan KR; Pollok KE; Case J
Angiogenesis; 2013 Oct; 16(4):953-62. PubMed ID: 23877751
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod.
Palamara F; Meindl S; Holcmann M; Lührs P; Stingl G; Sibilia M
J Immunol; 2004 Sep; 173(5):3051-61. PubMed ID: 15322165
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour.
Sharma A; Sharma D; Baldi A; Jyoti K; Chandra R; Madan J
J Microencapsul; 2019 Dec; 36(8):759-774. PubMed ID: 31587598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]